Meeta Gulyani

Meeta Gulyani is a globally recognized leader in the pharmaceutical and life sciences industry, with over 25 years of experience spanning Asia, Europe, and the U.S. Her career includes senior roles at Roche, Sanofi, Merck KGaA, Darmstadt, Germany, and now Ecolab, where she leads the Bioprocessing business and Life Sciences Strategy. Meeta has driven transformative initiatives—from expanding access to oncology treatments in South Asia to integrating the $17B Sigma-Aldrich acquisition, the largest in life sciences at the time. She has also championed sustainability, innovation, and equitable access to medicines.

Beyond corporate leadership, Meeta actively supports the innovation ecosystem through board roles and advisory work with Novo Holdings. A passionate advocate for diversity, she mentors women and underrepresented professionals across STEM fields. Her influence extends from shaping global investment strategies to fostering inclusive industry cultures. Recognized as a Boston Change Maker, Meeta continues to inspire progress, purpose, and impact across the pharma landscape.